CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

The Company’s Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Japan. CENTOGENE invites…

Adding significant financial expertise with an impressive track record in value creation

The Company’s Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Spain. CENTOGENE invites…

Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the…

Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule…

Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced…

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced…

Interim CFO Miguel Coego Rios appointed as Managing Director and permanent CFO. Centogene N.V. today announced the appointment of Miguel Coego Rios as…

Centogene N.V. today announced the voting results of the Company’s Annual General Meeting. Shareholders voted in favor of all proposals, which…

For Further Inquiries Please Contact

Press Contact

Ben Legg

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads